Bioventus Signs Pfizer as Exclusive DUROLANE Distributor in Brazil
Bioventus received ANVISA approval to market DUROLANE® single-injection in Brazil to treat hip osteoarthritis. Pfizer will serve as its exclusive...
Oct 02, 2018,
Bioventus Signs Pfizer as Exclusive DUROLANE Distributor in Brazil
Medacta Appoints New CEO, Francesco Siccardi
Medacta's current Executive Vice President, Francesco Siccardi, will become the company's next chief executive officer in November 2018....
Oct 02, 2018, Mike Evers
aap Receives Funding for Antibacterial Silver Coating Technology
aap Implantate will receive federal funding in Germany to pursue human clinical study of antibacterial silver coating technology that may inhibit bacterial...
Oct 01, 2018, Julie Vetalice
Vertos Medical Enrolls in New MOTION Study of MILD Procedure
Vertos Medical enrolled the first patient into MOTION, a new multicenter two-year U.S. study of the mild® outpatient procedure for...
Oct 01, 2018, Julie Vetalice
Episurf Medical to Commence Limited European Launch of Epioscopy Visualization Tool
Episurf Medical has announced limited European launch of the Epioscopy® artificial intelligence-based knee visualization tool....
Sep 28, 2018, Julie Vetalice
FDA Approves Update of Mobi-C Cervical Disc Labeling to Include 7-Year Clinical Results
FDA approved an update to the labeling for Zimmer Biomet's Mobi-C® Cervical Disc to include 7-year clinical results, showing the...
Sep 28, 2018, Julie Vetalice
Kuros Biosciences: First Procedure in MagnetOS Spinal Fusion Trial
The first patient has been treated in a multicenter study comparing Kuros Bioscience's MagnetOs bone graft substitute vs. autologous bone in...
Sep 28, 2018, Julie Vetalice
Episurf Medical Enters Polish Market
Episurf Medical plans to launch products in Poland, beginning with Episealer® knee implants....
Sep 27, 2018, Julie Vetalice
Alphatec Gains FDA Clearance for OsseoScrew
Alphatec received FDA 510(k) clearance to market the OsseoScrew® expandable pedicle screw. ...
Sep 27, 2018, Julie Vetalice
Renovis Surgical Receives FDA Clearance for Tesera X Lateral Interbody Fusion System
Renovis Surgical received FDA 510(k) clearance to market the Tesera® X Lateral Interbody Fusion system....
Sep 27, 2018, Julie Vetalice
Loading new posts...
No more posts
